Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KHK | P50053 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18128520 | 1.00 | ALDH1A1 (0.31) | ALDH1A1KHKL3MBTL1LMNAHPGD | |
| SCHEMBL31521270 | 0.88 | KHK (0.33) | ALDH1A1KHKL3MBTL1ENPP1 | |
| SCHEMBL18153433 | 0.86 | MAPK14 (0.37) | ALDH1A1KHKHPGDKMT2A | |
| SCHEMBL23986037 | 0.82 | ALDH1A1 (0.38) | ALDH1A1KHKL3MBTL1LMNAKMT2A | |
| SCHEMBL25805404 | 0.78 | L3MBTL1 (0.34) | ALDH1A1L3MBTL1HPGDKMT2AENPP1 | |
| SCHEMBL29876162 | 0.77 | KDM4E (0.31) | ALDH1A1KMT2A | |
| SCHEMBL18128716 | 0.77 | KDM4E (0.31) | ALDH1A1KMT2A | |
| SCHEMBL29654320 | 0.77 | ALDH1A1 (0.39) | ALDH1A1LMNAHPGD | |
| SCHEMBL24425031 | 0.77 | — | — | |
| SCHEMBL19104274 | 0.76 | KDM4E (0.30) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591588-A | RAS inhibitors | 泰励生物科技（上海）有限公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-4329888-A1 | 2-AMINOBENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF | Amgen Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-117651700-A | 2-aminobenzothiazole compounds and methods of use | 安进公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-116867779-A | KRAS inhibitors for cancer treatment | 泰励生物科技（上海）有限公司 | 2023-10-10 | — | — | CN | disclosed |
| WO-2022232332-A1 | 2-AMINOBENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF | AMGEN INC. (US) | 2022-11-03 | — | — | WO | disclosed |
| CN-114920738-A | KRas inhibitors for cancer treatment | 泰励生物科技（上海）有限公司 | 2022-08-19 | — | — | CN | disclosed |
| WO-2022095960-A1 | KRAS INHIBITORS FOR TREATMENT OF CANCERS | 泰励生物科技（上海）有限公司 | 2022-05-12 | — | — | WO | disclosed |